Kathleen Mullane to Chemoprevention
This is a "connection" page, showing publications Kathleen Mullane has written about Chemoprevention.
Connection Strength
0.146
-
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease. J Antimicrob Chemother. 2017 Dec 01; 72(12):3406-3413.
Score: 0.146